![Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet](https://www.thelancet.com/cms/asset/f3be98d8-d68c-4273-a286-fc9e5079f0d6/gr1.jpg)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
![Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study | University of Oxford Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study | University of Oxford](https://www.ox.ac.uk/sites/files/oxford/styles/ow_medium_feature/s3/field/field_image_main/Com-Cov%20news.jpg?itok=nNSxgFJO)
Mixed Oxford/Pfizer vaccine schedules generate robust immune response against COVID-19, finds Oxford-led study | University of Oxford
![JCVI issues advice on COVID-19 booster vaccines for those aged 40 to 49 and second doses for 16 to 17 year olds - GOV.UK JCVI issues advice on COVID-19 booster vaccines for those aged 40 to 49 and second doses for 16 to 17 year olds - GOV.UK](https://assets.publishing.service.gov.uk/media/61918ff3d3bf7f0559e1d94d/arm-vaccine-syringe-close-up.jpg)
JCVI issues advice on COVID-19 booster vaccines for those aged 40 to 49 and second doses for 16 to 17 year olds - GOV.UK
![Vaccinations may have prevented almost 20 million COVID-19 deaths worldwide | Imperial News | Imperial College London Vaccinations may have prevented almost 20 million COVID-19 deaths worldwide | Imperial News | Imperial College London](https://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1655980812742_mainnews2012_x1.jpg)
Vaccinations may have prevented almost 20 million COVID-19 deaths worldwide | Imperial News | Imperial College London
![Only one in four people experience mild systemic side effects from COVID-19 vaccines - King's College London Only one in four people experience mild systemic side effects from COVID-19 vaccines - King's College London](https://www.kcl.ac.uk/newimages/sspp/policy-institute/news/coronavirus/covid-vaccine.x5df17486.jpg)